Xianju Pharmaceutical: Announcement on holding investor reception day event
Securities code: 002332 Securities abbreviation: Xianju Pharmaceutical Announcement number: 2026-019
Zhejiang Xianju Pharmaceutical Co., Ltd.
Announcement on holding investor reception day activities
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and that there are no false records, misleading statements or major omissions.
Zhejiang Xianju Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") released the "2025 Annual Report" on April 23, 2026. In order to facilitate investors to have an in-depth and comprehensive understanding of the company's situation, the company will hold an investor reception day event. The relevant matters are now announced as follows:
1. Activity time
May 19, 2026 (Tuesday) 9:30-11:30 am.
2. Activity location
Company conference room, No. 15, Fengxi West Road, Modern Industrial Cluster Area, Fuying Street, Xianju County, Zhejiang Province.
3. Reservation method
Participating investors should contact the company’s board secretary office on May 15, 2026 (8:30-11:00 am 13:00-17:00) to make an appointment and register in advance, and provide an outline of issues for reception registration and arrangements. Contact number: 0576-87731138
4. Company participants
Chairman Mr. Zhang Yusong, General Manager Mr. Jin Weihua, Deputy General Manager Mr. Zou Wenhui, Financial Director Ms. Wang Yaohua, Deputy General Manager and Board Secretary Mr. Zhang Wangwei (if there are special circumstances, the participants will be adjusted).
5. Things to note
Visiting individual investors are required to bring the original and copy of their personal ID card, original and copy of shareholder card, and institutional investors are required to bring relevant certification documents and their copies. The company will inspect the above-mentioned supporting documents of the visiting investors and archive copies for review by regulatory agencies. Visitors are responsible for their own food, accommodation and transportation expenses.
Confidentiality commitment: The company will require investors to sign a "Letter of Commitment" in accordance with the regulations of the Shenzhen Stock Exchange.
In order to improve reception efficiency, before the reception day, investors can raise their concerns to the Office of the Secretary of the Board of Directors by phone, email, etc., and the company will formulate responses to relatively concentrated issues. We sincerely thank all investors for their concern and support for the company! Investors are welcome to actively participate.
Announcement is hereby made.
Board of Directors of Zhejiang Xianju Pharmaceutical Co., Ltd.
April 28, 2026